To assess the prevalence of malignancy in symptomatic and asymptomatic patients with pure MD-IPMN based on MPD size.
Single-center retrospective study of prospectively collected data.
Tertiary referral center.
Fifty-two patients with pure low-risk MD-IPMN. Clinical, endoscopic, radiographic, and pathologic data were reviewed.
Prevalence of malignancy in patients with pure MD-IPMN based on histopathology of resected lesions.
Sixteen asymptomatic patients had pure MD-IPMN on surgical pathology, 4 (25%) with malignant disease, compared with 25 of 36 symptomatic patients (69%) with pure MD-IPMN. Logistic regression identified symptoms and MPD size as predictors of malignancy. Receiver operating characteristic curve analysis demonstrated that MPD size (optimal cutoff of 8聽mm) produced the greatest area under the curve to discriminate between benign and malignant MD-IPMN (.83; 95% CI, .72-.94). MPD size greater than 8聽mm has a relative risk of 2.8 for malignancy (95% CI, 1.6-4.9).
Retrospective, single-center study at a tertiary referral hospital. Study population included only patients who underwent surgical resection.
Asymptomatic MD-IPMN patients with a duct size of no more than 8聽mm have a lower prevalence of malignancy and may represent a distinct group of patients with less aggressive biologic behavior. Further studies are needed to confirm our observations.